Q4 2021 Holdings
Filed 2022-02-14 | 83 holdings | $473.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $137.5M | 3,398,067 | 29.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $85.3M | 3,003,879 | 18.0% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $82.9M | 5,369,459 | 17.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $75.7M | 216,204 | 16.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $25.1M | 5,803,700 | 5.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $24.7M | 1,695,904 | 5.2% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $21.7M | 899,392 | 4.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.1M | 1,532,282 | 2.8% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.3M | 1,370,947 | 0.7% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $2.0M | 289,663 | 0.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $216.4K | 9,275,158 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $201.9K | 3,180,658 | 0.0% |
| Merus N V | COM | N5749R100 | $131.5K | 4,135,071 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $124.9K | 3,651,759 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $102.8K | 3,289,540 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $102.5K | 4,858,761 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $96.1K | 3,130,605 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $73.6K | 3,530,543 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $69.4K | 7,411,503 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $63.8K | 1,156,393 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $56.6K | 14,360,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $55.5K | 16,459,965 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $53.6K | 7,859,670 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $46.0K | 2,099,714 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.6K | 1,810,549 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $44.0K | 2,005,862 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $40.5K | 2,851,461 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $38.1K | 2,957,807 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $37.2K | 1,879,412 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $37.1K | 1,647,400 | 0.0% |
| Verastem Inc | COM | 92337C104 | $35.0K | 17,062,158 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $35.0K | 7,062,379 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $29.4K | 1,800,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $28.9K | 2,064,212 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $26.4K | 1,873,332 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $25.4K | 1,585,615 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $25.1K | 926,529 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $22.6K | 1,798,371 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $22.1K | 8,929,690 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $22.0K | 1,589,495 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $21.3K | 6,631,051 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $20.1K | 5,328,239 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $20.1K | 1,017,314 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $19.7K | 1,791,351 | 0.0% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $18.6K | 750,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $16.9K | 955,000 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $16.4K | 2,920,526 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $15.6K | 666,666 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $14.3K | 6,353,645 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $13.8K | 925,148 | 0.0% |